My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.

    Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch C, Hauser J, Mace K, Niederberger P.

    Lipids Health Dis. 2004 Feb 18;3:2.PMID: 14969592 [PubMed]Free PMC ArticleFree textRelated citations

    3.

    Reduced and high molecular weight barley beta-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic Syrian golden hamsters.

    Wilson TA, Nicolosi RJ, Delaney B, Chadwell K, Moolchandani V, Kotyla T, Ponduru S, Zheng GH, Hess R, Knutson N, Curry L, Kolberg L, Goulson M, Ostergren K.

    J Nutr. 2004 Oct;134(10):2617-22.PMID: 15465756 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    4.

    Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.

    Hajjaj H, Macé C, Roberts M, Niederberger P, Fay LB.

    Appl Environ Microbiol. 2005 Jul;71(7):3653-8.PMID: 16000773 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    5.

    Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet.

    Sandhya VG, Rajamohan T.

    Food Chem Toxicol. 2008 Dec;46(12):3586-92. Epub 2008 Sep 3.PMID: 18809454 [PubMed - indexed for MEDLINE]Related citations

    6.

    Triterpenic Acids Present in Hawthorn Lower Plasma Cholesterol by Inhibiting Intestinal ACAT Activity in Hamsters.

    Lin Y, Vermeer MA, A Trautwein E.

    Evid Based Complement Alternat Med. 2009 Feb 19. [Epub ahead of print]PMID: 19228775 [PubMed - as supplied by publisher]Free ArticleRelated citations

    7.

    Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.

    Castaño G, Fernández L, Mas R, Illnait J, Mesa M, Fernández JC.

    Clin Drug Investig. 2003;23(10):639-50.PMID: 17535079 [PubMed - in process]Related citations

    8.

    Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods.

    Zhang Z, Wang H, Jiao R, Peng C, Wong YM, Yeung VS, Huang Y, Chen ZY.

    Mol Nutr Food Res. 2009 Jul;53(7):921-30.PMID: 19536872 [PubMed - indexed for MEDLINE]Related citations

    9.

    Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.

    Gouni-Berthold I, Berthold HK, Gylling H, Hallikainen M, Giannakidou E, Stier S, Ko Y, Patel D, Soutar AK, Seedorf U, Mantzoros CS, Plat J, Krone W.

    Atherosclerosis. 2008 May;198(1):198-207. Epub 2007 Nov 5.PMID: 17980884 [PubMed - indexed for MEDLINE]Related citations

    10.

    Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

    Evans M, Roberts A, Davies S, Rees A.

    Drugs. 2004;64(11):1181-96. Review.PMID: 15161326 [PubMed - indexed for MEDLINE]Related citations

    11.

    Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.

    Nakamura S, Kamiya S, Shirahase H, Kanda M, Yoshimi A, Tarumi T, Kurahashi K.

    Arzneimittelforschung. 2004;54(2):102-8.PMID: 15038459 [PubMed - indexed for MEDLINE]Related citations

    12.

    Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters.

    Ng CH, Leung KY, Huang Y, Chen ZY.

    J Agric Food Chem. 2005 Aug 10;53(16):6289-93.PMID: 16076108 [PubMed - indexed for MEDLINE]Related citations

    13.

    Soyasaponins lowered plasma cholesterol and increased fecal bile acids in female golden Syrian hamsters.

    Lee SO, Simons AL, Murphy PA, Hendrich S.

    Exp Biol Med (Maywood). 2005 Jul;230(7):472-8.PMID: 15985622 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    14.

    Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia.

    Weidner C, Krempf M, Bard JM, Cazaubiel M, Bell D.

    Lipids Health Dis. 2008 Oct 6;7:35.PMID: 18837970 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    15.

    JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.

    Aggarwal D, West KL, Zern TL, Shrestha S, Vergara-Jimenez M, Fernandez ML.

    BMC Cardiovasc Disord. 2005 Sep 27;5:30.PMID: 16188040 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    16.

    HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.

    Liang K, Kim CH, Vaziri ND.

    Am J Physiol Renal Physiol. 2005 Mar;288(3):F539-44. Epub 2004 Oct 26.PMID: 15507547 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    17.

    Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters.

    Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D.

    J Nutr Biochem. 2007 Feb;18(2):105-12. Epub 2006 May 18.PMID: 16713234 [PubMed - indexed for MEDLINE]Related citations

    18.

    A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.

    Telford DE, Lipson SM, Barrett PH, Sutherland BG, Edwards JY, Aebi JD, Dehmlow H, Morand OH, Huff MW.

    Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2608-14. Epub 2005 Oct 6.PMID: 16210564 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    19.

    Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.

    Delsing DJ, Post SM, Groenendijk M, Solaas K, van der Boom H, van Duyvenvoorde W, de Wit EC, Bloks VW, Kuipers F, Havekes LM, Princen HM.

    J Cardiovasc Pharmacol. 2005 Jan;45(1):53-60.PMID: 15613980 [PubMed - indexed for MEDLINE]Related citations

    20.

    The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.

    Kural BV, Orem C, Uydu HA, Alver A, Orem A.

    Coron Artery Dis. 2004 Aug;15(5):277-83.PMID: 15238825 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk